Table 3.
Adverse Event | No. of Patients (%) |
---|---|
Grade 3 or 4 adverse event | 175 (50) |
Drug‐related | 85 (24) |
Thrombocytopenia | 53 (15) |
Anemia | 47 (14) |
Neutropenia | 28 (8) |
Lymphopenia | 22 (6) |
Hypercalcemia | 17 (5) |
These were adverse events reported in ≥1% of patients.